RGT-M001, a first-in-class small molecule mRNA degrader of the oncogenic transcription factor c-Myb, demonstrated remarkable single agent anti-tumor efficacy in cancer patient-derived xenograft model

AL101 - Immunome

Lenvima (lenvatinib) - Eisai, Merck (MSD)

RGT-M001 - Rgenta Therap

N. Lu 1; P. Soulard 1; K. Li 1; H. Sadlish 1; C. Yates 1; X. Gu 1; I. Kays 1; J. Lee 1; S. Hasson 1; Z. Weng 2; S. Xi 1; T. Wager1

Mar 6, 2024